BioPharma Credit - A quality dividend play with FY22 yield of 12%
BioPharma Credit (BPCR) is on track to deliver a strong (possibly record-high) annual NAV total return (TR) in FY22 on the back of a high...
362 Views
BioPharma Credit - New transaction of up to US$50m
BioPharma Credit (BPCR) has entered into a new senior secured loan agreement for up to US$50m to be provided to UroGen Pharma, a Nasdaq-listed...
799 Views
BioPharma Credit - Now listed in the Premium Segment of LSE
BioPharma Credit (BPCR) delivered a 7.3% NAV total return (NAV TR) pa in the three-year period ending 30 September 2021 (Edison calculations),...
344 Views
BioPharma Credit - Debt investment in Collegium Pharmaceutical
BioPharma Credit (BPCR) has entered into a definitive agreement to provide US$165m in a single-tranche senior secured loan to Collegium...
551 Views
BioPharma Credit - High investment volume in H219
BioPharma Credit (BPCR) offers investors access to a diverse portfolio of secured debt instruments for life science companies. During 2019, BPCR...
820 Views